Free Trial

Sotera Health (SHC) Stock Forecast & Price Target

Sotera Health logo
$13.55 +0.22 (+1.65%)
(As of 12/24/2024 02:00 PM ET)

Sotera Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
4

Based on 7 Wall Street analysts who have issued ratings for Sotera Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 3 have given a hold rating, and 4 have given a buy rating for SHC.

Consensus Price Target

$16.08
18.70% Upside
According to the 7 analysts' twelve-month price targets for Sotera Health, the average price target is $16.08. The highest price target for SHC is $20.00, while the lowest price target for SHC is $13.00. The average price target represents a forecasted upside of 18.70% from the current price of $13.55.
Get the Latest News and Ratings for SHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Sotera Health and its competitors.

Sign Up

SHC Analyst Ratings Over Time

TypeCurrent Forecast
12/26/23 to 12/25/24
1 Month Ago
11/26/23 to 11/25/24
3 Months Ago
9/27/23 to 9/26/24
1 Year Ago
12/26/22 to 12/26/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
Hold
3 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$16.08$16.50$15.70$20.20
Forecasted Upside18.70% Upside24.06% Upside-5.36% Downside18.48% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
[PDF] The Opportunity in Gold (Ad)

Commodities expert, Geof Smith, insists that the supercycle on gold is just getting warmed up. In fact, even though gold looks like this since he initially called a major bull run 11 months ago… He’s still predicting it will be the TOP trade of 2025. His free eBook explains why You see, the last time gold launched into a supercycle like this it surged 536% The time before that was over 1,000%... That’s why Geof released this urgent guide to help you. Most people think they’ve missed out, but he thinks we’re at the very beginning of what could be the largest gold rally of our lifetimes. But, believe it or not, Geof doesn’t think you should just buy and hold precious metals. He’ll share more about his approach inside the eBook and it might surprise you.

Tap here to read it

SHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sotera Health Stock vs. The Competition

TypeSotera HealthMedical CompaniesS&P 500
Consensus Rating Score
2.57
2.81
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside18.70% Upside26,167.05% Upside13.49% Upside
News Sentiment Rating
Positive News

See Recent SHC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/6/2024The Goldman Sachs Group
3 of 5 stars
M. Sykes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$14.00+7.90%
11/21/2024Royal Bank of Canada
4 of 5 stars
 Reiterated RatingOutperform ➝ Outperform$17.00 ➝ $17.00+32.09%
11/6/2024Citigroup
3 of 5 stars
 Boost TargetBuy ➝ Buy$18.00 ➝ $20.00+25.79%
8/6/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$14.00 ➝ $17.00+16.76%
5/21/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Bednar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$13.00+17.22%
3/25/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$15.00 ➝ $15.50+37.17%
2/6/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSector Weight
1/23/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Neutral$6.00 ➝ $18.00+6.38%
1/10/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradePeer Perform ➝ Outperform$25.00+44.93%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:11 AM ET.


SHC Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Sotera Health is $16.08, with a high forecast of $20.00 and a low forecast of $13.00.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sotera Health in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SHC shares.

According to analysts, Sotera Health's stock has a predicted upside of 18.70% based on their 12-month stock forecasts.

Sotera Health has been rated by research analysts at Citigroup, Royal Bank of Canada, and The Goldman Sachs Group in the past 90 days.

Analysts like Sotera Health less than other "medical" companies. The consensus rating score for Sotera Health is 2.57 while the average consensus rating score for "medical" companies is 2.81. Learn more on how SHC compares to other companies.


This page (NASDAQ:SHC) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners